Topochemical catalysis achieved by structure-based ligand design

被引:8
|
作者
Katz, BA
Cass, RT
Liu, BS
Arze, R
Collins, N
机构
[1] Arris Pharmaceutical Corporation, South San Francisco
关键词
D O I
10.1074/jbc.270.52.31210
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recently, a cyclic peptide ligand, cyclo-Ac-[CHPQG-PPC]-NH2, that binds to streptavidin with high affinity was discovered by screening phage libraries, From the streptavidin-bound crystal structures of cyclo-Ac[CHPQGPPC]-NH2 and of a related but more weakly binding linear ligand, FSHPQNT, we designed linear thiol-containing streptavidin binding ligands, FCH-PQNT-NH2, and Ac-CHPQNT-NH2, which are dimerized catalytically by the streptavidin crystal lattice of space group I222, as demonstrated by high performance liquid chromatography and mass spectrometry, The catalytic dimerization relies on presentation of the ligand thiols toward one another in the lattice, The streptavidin crystal lattice mediated catalysis achieved by structure-based design is the first example of catalysis of a chemical reaction by a protein crystal lattice, The spontaneous and crystal catalyzed rates of disulfide formation were determined by high performance liquid chromatography at pH 3.1, 4.0, 5.0, and 6.0. The ratio of the catalyzed to uncatalyzed rate was maximal at pH 3.1 (k(cat)/k(uncat) = 3.8), diminishing to 1.2 at pH 6.0. The crystal structures of the streptavidin bound dimerized peptide ligands, FCHPQNT-NH2 dimer at 1.95 Angstrom and Ac-CHPQNT-NH22 dimer at 1.80 Angstrom, are described and compared with the structures of streptavidin-bound FSHPQNT monomer and cyclo-Ac-[CHPQGPPC]-NH2 dimer.
引用
收藏
页码:31210 / 31218
页数:9
相关论文
共 50 条
  • [1] Combining ligand and structure-based design
    McGann, Mark
    Skillman, Geoff
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 214 - 214
  • [2] Computational approaches to structure-based ligand design
    Joseph-McCarthy, D
    PHARMACOLOGY & THERAPEUTICS, 1999, 84 (02) : 179 - 191
  • [3] Computational tools for structure-based ligand design
    Bohm, HJ
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1996, 66 (03): : 197 - 210
  • [4] Challenges and progress in structure-based ligand design.
    Johnson, AP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 50 - CINF
  • [5] Ligand docking for structure-based drug design.
    Jiang, X
    Venkatachalam, CM
    Oldfield, T
    Waldman, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U697 - U697
  • [6] Geometric Deep Learning for Structure-Based Ligand Design
    Powers, Alexander S.
    Yu, Helen H.
    Suriana, Patricia
    Koodli, Rohan V.
    Lu, Tianyu
    Paggi, Joseph M.
    Dror, Ron O.
    ACS CENTRAL SCIENCE, 2023, 9 (12) : 2257 - 2267
  • [7] Structure-based ligand design for RNA targets.
    Hermann, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : U469 - U469
  • [8] Class A GPCRs: Structure, Function, Modeling and Structure-based Ligand Design
    Cong, Xiaojing
    Topin, Jeremie
    Golebiowski, Jerome
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (29) : 4390 - 4409
  • [9] Protein Structure Prediction in Structure-Based Ligand Design and Virtual Screening
    Grant, Marianne A.
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2009, 12 (10) : 940 - 960
  • [10] STRUCTURE-BASED DESIGN OF A CYCLOPHILIN-CALCINEURIN BRIDGING LIGAND
    ALBERG, DG
    SCHREIBER, SL
    SCIENCE, 1993, 262 (5131) : 248 - 250